AMANDA FALLOS: Open Payments
NPI 1225364748 · MT JULIET, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,130 in 126 payments from 28 companies in 2025. Trend: 2023 $2,495 · 2024 $2,136 · 2025 $2,130
Food & beverage: $2,130
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $260 |
| Novo Nordisk Inc | 21 | $241 |
| Corcept Therapeutics | 11 | $218 |
| AstraZeneca Pharmaceuticals LP | 7 | $216 |
| PFIZER INC. | 11 | $185 |
| GlaxoSmithKline, LLC. | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $87 |
| Lundbeck LLC | 3 | $65 |
Products named: Korlym, FARXIGA, REXULTI, VRAYLAR, TRELEGY ELLIPTA, NURTEC ODT, UBRELVY, Ozempic.
Industry payments across TN — which companies pay providers there.
